Medical Care

Global Cell and Gene Therapy Manufacturing QC Market Research Report 2025

The global market for Cell and Gene Therapy Manufacturing QC was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Manufacturing QC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Manufacturing QC.
The Cell and Gene Therapy Manufacturing QC market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy Manufacturing QC market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Manufacturing QC companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne Corporation
BioMerieux SA
Catalent, Inc.
Charles River Laboratories International Inc.
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Intertek Group plc
Lonza Group AG
Merck KGaA
Sartorius AG
SGS S.A.
Sistemic Scotland Limited
Thermo Fisher Scientific Inc.
Vigene Biosciences, Inc.
WuXi AppTec
Segment by Type
Safety Testing
Purity Testing
Potency Testing
Identity Testing
Stability Testing
Segment by Application
Precision Therapy
Biological Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Manufacturing QC company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Safety Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Stability Testing
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Precision Therapy
1.3.3 Biological Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Manufacturing QC Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Manufacturing QC Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing QC Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Manufacturing QC Revenue
3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Manufacturing QC Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Manufacturing QC, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Manufacturing QC, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing QC Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Manufacturing QC Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Details
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.1.5 Bio-Techne Corporation Recent Development
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Details
11.2.2 BioMerieux SA Business Overview
11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.2.5 BioMerieux SA Recent Development
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Details
11.3.2 Catalent, Inc. Business Overview
11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.3.5 Catalent, Inc. Recent Development
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Details
11.4.2 Charles River Laboratories International Inc. Business Overview
11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.4.5 Charles River Laboratories International Inc. Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Details
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.5.5 Eurofins Scientific SE Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Details
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Intertek Group plc
11.7.1 Intertek Group plc Company Details
11.7.2 Intertek Group plc Business Overview
11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.7.5 Intertek Group plc Recent Development
11.8 Lonza Group AG
11.8.1 Lonza Group AG Company Details
11.8.2 Lonza Group AG Business Overview
11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.8.5 Lonza Group AG Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.9.5 Merck KGaA Recent Development
11.10 Sartorius AG
11.10.1 Sartorius AG Company Details
11.10.2 Sartorius AG Business Overview
11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.10.5 Sartorius AG Recent Development
11.11 SGS S.A.
11.11.1 SGS S.A. Company Details
11.11.2 SGS S.A. Business Overview
11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.11.5 SGS S.A. Recent Development
11.12 Sistemic Scotland Limited
11.12.1 Sistemic Scotland Limited Company Details
11.12.2 Sistemic Scotland Limited Business Overview
11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.12.5 Sistemic Scotland Limited Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Details
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
11.14 Vigene Biosciences, Inc.
11.14.1 Vigene Biosciences, Inc. Company Details
11.14.2 Vigene Biosciences, Inc. Business Overview
11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.14.5 Vigene Biosciences, Inc. Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
11.15.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Safety Testing
Table 3. Key Players of Purity Testing
Table 4. Key Players of Potency Testing
Table 5. Key Players of Identity Testing
Table 6. Key Players of Stability Testing
Table 7. Global Cell and Gene Therapy Manufacturing QC Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Cell and Gene Therapy Manufacturing QC Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Cell and Gene Therapy Manufacturing QC Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing QC Market Share by Region (2020-2025)
Table 11. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Cell and Gene Therapy Manufacturing QC Market Share by Region (2026-2031)
Table 13. Cell and Gene Therapy Manufacturing QC Market Trends
Table 14. Cell and Gene Therapy Manufacturing QC Market Drivers
Table 15. Cell and Gene Therapy Manufacturing QC Market Challenges
Table 16. Cell and Gene Therapy Manufacturing QC Market Restraints
Table 17. Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Cell and Gene Therapy Manufacturing QC Market Share by Players (2020-2025)
Table 19. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2024)
Table 20. Ranking of Global Top Cell and Gene Therapy Manufacturing QC Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Cell and Gene Therapy Manufacturing QC, Headquarters and Area Served
Table 23. Global Key Players of Cell and Gene Therapy Manufacturing QC, Product and Application
Table 24. Global Key Players of Cell and Gene Therapy Manufacturing QC, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell and Gene Therapy Manufacturing QC Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2020-2025)
Table 28. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2026-2031)
Table 30. Global Cell and Gene Therapy Manufacturing QC Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2020-2025)
Table 32. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2026-2031)
Table 34. North America Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2026-2031) & (US$ Million)
Table 49. Bio-Techne Corporation Company Details
Table 50. Bio-Techne Corporation Business Overview
Table 51. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product
Table 52. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 53. Bio-Techne Corporation Recent Development
Table 54. BioMerieux SA Company Details
Table 55. BioMerieux SA Business Overview
Table 56. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product
Table 57. BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 58. BioMerieux SA Recent Development
Table 59. Catalent, Inc. Company Details
Table 60. Catalent, Inc. Business Overview
Table 61. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 62. Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 63. Catalent, Inc. Recent Development
Table 64. Charles River Laboratories International Inc. Company Details
Table 65. Charles River Laboratories International Inc. Business Overview
Table 66. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product
Table 67. Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 68. Charles River Laboratories International Inc. Recent Development
Table 69. Eurofins Scientific SE Company Details
Table 70. Eurofins Scientific SE Business Overview
Table 71. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product
Table 72. Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 73. Eurofins Scientific SE Recent Development
Table 74. F. Hoffmann-La Roche Ltd Company Details
Table 75. F. Hoffmann-La Roche Ltd Business Overview
Table 76. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product
Table 77. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd Recent Development
Table 79. Intertek Group plc Company Details
Table 80. Intertek Group plc Business Overview
Table 81. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product
Table 82. Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 83. Intertek Group plc Recent Development
Table 84. Lonza Group AG Company Details
Table 85. Lonza Group AG Business Overview
Table 86. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product
Table 87. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 88. Lonza Group AG Recent Development
Table 89. Merck KGaA Company Details
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Cell and Gene Therapy Manufacturing QC Product
Table 92. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Sartorius AG Company Details
Table 95. Sartorius AG Business Overview
Table 96. Sartorius AG Cell and Gene Therapy Manufacturing QC Product
Table 97. Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 98. Sartorius AG Recent Development
Table 99. SGS S.A. Company Details
Table 100. SGS S.A. Business Overview
Table 101. SGS S.A. Cell and Gene Therapy Manufacturing QC Product
Table 102. SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 103. SGS S.A. Recent Development
Table 104. Sistemic Scotland Limited Company Details
Table 105. Sistemic Scotland Limited Business Overview
Table 106. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product
Table 107. Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 108. Sistemic Scotland Limited Recent Development
Table 109. Thermo Fisher Scientific Inc. Company Details
Table 110. Thermo Fisher Scientific Inc. Business Overview
Table 111. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product
Table 112. Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 113. Thermo Fisher Scientific Inc. Recent Development
Table 114. Vigene Biosciences, Inc. Company Details
Table 115. Vigene Biosciences, Inc. Business Overview
Table 116. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 117. Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 118. Vigene Biosciences, Inc. Recent Development
Table 119. WuXi AppTec Company Details
Table 120. WuXi AppTec Business Overview
Table 121. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product
Table 122. WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2020-2025) & (US$ Million)
Table 123. WuXi AppTec Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report


List of Figures
Figure 1. Cell and Gene Therapy Manufacturing QC Picture
Figure 2. Global Cell and Gene Therapy Manufacturing QC Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell and Gene Therapy Manufacturing QC Market Share by Type: 2024 VS 2031
Figure 4. Safety Testing Features
Figure 5. Purity Testing Features
Figure 6. Potency Testing Features
Figure 7. Identity Testing Features
Figure 8. Stability Testing Features
Figure 9. Global Cell and Gene Therapy Manufacturing QC Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2024 VS 2031
Figure 11. Precision Therapy Case Studies
Figure 12. Biological Research Case Studies
Figure 13. Cell and Gene Therapy Manufacturing QC Report Years Considered
Figure 14. Global Cell and Gene Therapy Manufacturing QC Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Cell and Gene Therapy Manufacturing QC Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Cell and Gene Therapy Manufacturing QC Market Share by Region: 2024 VS 2031
Figure 17. Global Cell and Gene Therapy Manufacturing QC Market Share by Players in 2024
Figure 18. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2024
Figure 20. North America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Cell and Gene Therapy Manufacturing QC Market Share by Country (2020-2031)
Figure 22. United States Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Cell and Gene Therapy Manufacturing QC Market Share by Country (2020-2031)
Figure 26. Germany Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Region (2020-2031)
Figure 34. China Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Country (2020-2031)
Figure 42. Mexico Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Share by Country (2020-2031)
Figure 46. Turkey Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Bio-Techne Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 50. BioMerieux SA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 51. Catalent, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 52. Charles River Laboratories International Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 53. Eurofins Scientific SE Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 54. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 55. Intertek Group plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 56. Lonza Group AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 57. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 58. Sartorius AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 59. SGS S.A. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 60. Sistemic Scotland Limited Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 61. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 62. Vigene Biosciences, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 63. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies